Schedule 13G ownership disclosure
PDL BIOPHARMA INC
Security class unavailable · CUSIP: 69329Y104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 31,192,401
- Percent of class
- 19.0100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001445546-15-002886
- Form type
- SC 13G
- Filer
- FIRST TRUST PORTFOLIOS LP
- CIK
- CIK 1184765
- Filed
- Jun 10, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership